These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. "Clonal selection and after," and after. Gershon RK N Engl J Med; 1979 May; 300(19):1105-7. PubMed ID: 34794 [No Abstract] [Full Text] [Related]
4. [Immunology of bone marrow grafts]. Dreyfus F Ann Med Interne (Paris); 1986; 137(8):617-20. PubMed ID: 3551717 [No Abstract] [Full Text] [Related]
5. Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts. Kiessling R; Hochman PS; Haller O; Shearer GM; Wigzell H; Cudkowicz G Eur J Immunol; 1977 Sep; 7(9):655-63. PubMed ID: 336380 [No Abstract] [Full Text] [Related]
6. Use of lymphokine-activated killer cells to prevent bone marrow graft rejection and lethal graft-vs-host disease. Azuma E; Yamamoto H; Kaplan J J Immunol; 1989 Sep; 143(5):1524-9. PubMed ID: 2668409 [TBL] [Abstract][Full Text] [Related]
7. Natural killer (NK) cells and their possible roles in resistance against disease. Herberman RB Clin Immunol Rev; 1981; 1(1):1-65. PubMed ID: 6219848 [No Abstract] [Full Text] [Related]
8. Graft-versus-leukaemia after bone marrow transplantation. Barret AJ Pediatr Med Chir; 1991; 13(1):9-13. PubMed ID: 2052462 [No Abstract] [Full Text] [Related]
9. Regulation of natural killer cell function: a role for the NK cell's own MHC class I molecules. Held W; Chalifour A; Coudert JD Med Microbiol Immunol; 2005 Aug; 194(4):169-74. PubMed ID: 15660246 [No Abstract] [Full Text] [Related]
10. Donor T cell and host NK depletion improve the therapeutic efficacy of allogeneic bone marrow cell reconstitution in the nonmyeloablatively conditioned tumor-bearing host. Hummel S; Wilms D; Vitacolonna M; Zöller M J Leukoc Biol; 2002 Nov; 72(5):898-912. PubMed ID: 12429711 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: role of natural killer T cells. Liu YP; Li Z; Nador RG; Strober S Transplantation; 2008 Feb; 85(4):607-14. PubMed ID: 18347541 [TBL] [Abstract][Full Text] [Related]
12. Graft-versus-host disease in recipients of syngeneic bone marrow. Olsson L; Kiger N; Mathé G Lancet; 1980 Feb; 1(8162):253. PubMed ID: 6101696 [No Abstract] [Full Text] [Related]
16. Natural killer cells and their possible relevance to transplantation biology. Herberman RB Transplantation; 1982 Jul; 34(1):1-7. PubMed ID: 6214877 [No Abstract] [Full Text] [Related]
17. Association between pre-transplant natural kill and graft-versus-host disease after stem-cell transplantation. Lopez C; Kirkpatrick D; Sorell M; O'Reilly RJ; Ching C Lancet; 1979 Nov; 2(8152):1103-7. PubMed ID: 91840 [TBL] [Abstract][Full Text] [Related]
18. Natural immunity to tumours--theoretical predictions and biological observations. Moore M Br J Cancer; 1985 Aug; 52(2):147-51. PubMed ID: 3896287 [No Abstract] [Full Text] [Related]
19. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation. Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943 [TBL] [Abstract][Full Text] [Related]
20. Life history of cells mediating natural resistance to tumor cells and bone-marrow transplants: the respective roles of cell lineage commitment and host environment in determining strain characteristics of natural resistance to foreign marrow grafts. Miller SC Am J Anat; 1984 Jul; 170(3):367-76. PubMed ID: 6383004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]